2019—2023年中国抗癌协会科技奖获奖项目分析  被引量:1

Analysis of the Award-Winning Projects of China AntiCancer Association Science and Technology Award from 2019 to 2023

在线阅读下载全文

作  者:孙金金 张馨予[2] 杨芸 王耀刚[2] SUN Jinjin;ZHANG Xinyu;YANG Yun;WANG Yaogang(Tianjin Medical University Cancer Institute and Hospital,Tianjin 300060,China;School of Public Health,Tianjin Medical University,Tianjin 300070,China;China Anti-Cancer Association,Tianjin 300384,China)

机构地区:[1]天津医科大学肿瘤医院,天津300060 [2]天津医科大学公共卫生学院,天津300070 [3]中国抗癌协会,天津300384

出  处:《中国肿瘤》2024年第9期763-768,共6页China Cancer

基  金:中国科协中国特色一流学会建设项目(2021ZZ111512)。

摘  要:[目的]对2019—2023年中国抗癌协会科技奖获奖项目进行分析,为肿瘤医学人才培育、研究布局及学科发展提供参考。[方法]通过描述性统计分析法对2019—2023年中国抗癌协会科技奖奖励数量、学科分布、任务来源、论文质量、完成人、完成单位、地区分布进行分析。[结果]2019—2023年中国抗癌协会科技奖中,肿瘤基础研究项目申报(20.63%,98/475)较少,获奖率(15.31%,15/98)较低,获奖项目多数具有国家级项目资助和高水平论文发表,获奖完成人呈年轻化趋势,医院申报数(89.47%,425/475)较多,获奖率(18.35%,78/425)较高,东部和中西部地区获奖数存在较大差异。[结论]建议加强基础医学领域研究力量的激励,构建高水平成果梯队和科研育人的培养机制,中西部地区要优化医学科技资源配置,增强社会各界协同创新。[Purpose]To analyze the Science and Technology award-winning projects of the China Anti-Cancer Association from 2019 to 2023,to provide reference for talent cultivation,research scheme,and disciplinary development of oncology.[Methods]The award number,subject distribution,funding sources,quality of publication,award winners,units and regions were analyzed with descriptive statistical methods.[Results]In total 84 award-winning projects from 2019 to 2023,the proportion of applications and awards in fields of cancer basic research(20.63%,98/475;15.31%,15/89)was relatively small;most award-winning projects were supported by national research funding with high-level paper publication.The age of award winner showed a younger trend and more applicants and winners were from hospitals(89.47%,425/475;18.35%,78/425)rather than from universities or academic institutions.The regional distribution showed more awards were won by eastern regions than by western regions.[Conclusion]The study suggests that more incentive measures for basic medical sciences are necessary,building high-level teams for scientific research training is essential,optimizing the resource allocation in the central and western regions and promoting collaborative innovation should be strengthened.

关 键 词:肿瘤医学 科技奖励 中国抗癌协会 

分 类 号:R73[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象